Influence of Rosiglitazone on the Expression of PPARγ, NF-κB, and TNF-α in Rat Model of Ulcerative Colitis

Table 4

Colonic mucosal protein expression of PPARγ, NF-κB, and TNF-α (mean ± SD).

Time	Control group			Model group			Rosiglitazone-treated group
	PPARγ	NF-κB	TNF-α	PPARγ	NF-κB	TNF-α	PPARγ	NF-κB	TNF-α
7th d	0.04±0.01	0.02±0.01	0.01±0.00	0.01±0.00 *	0.13±0.01 *	0.10±0.01 *	0.02±0.01^Δ	0.09±0.01^Δ	0.08±0.01^Δ
14th d	0.04±0.00	0.02±0.00	0.001±0.00	0.00±0.00 *	0.11±0.01 *	0.07±0.01 *	0.02±0.00^Δ	0.07±0.01^Δ	0.05±0.01^Δ
21st d	0.04±0.01	0.03±0.00	0.00±0.00	0.01±0.00 *	0.09±0.01 *	0.06±0.01 *	0.02±0.01^Δ	0.06±0.01^Δ	0.02±0.01^Δ
35th d	0.04±0.00	0.02±0.01	0.01±0.00	0.01±0.00 *	0.07±0.01 *	0.05±0.01 *	0.03±0.01^Δ	0.04±0.00^Δ	0.02±0.00^Δ

Note: *𝑃<0.05 versus control group, ^Δ𝑃<0.05 versus model group.